|
|
Volumn 93, Issue 2, 2015, Pages e178-e179
|
|
Short-term efficacy of intravitreal triamcinolone acetonide for bevacizumab-resistant diabetic macular oedema
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIGLAUCOMA AGENT;
BEVACIZUMAB;
TRIAMCINOLONE ACETONIDE;
ANGIOGENESIS INHIBITOR;
GLUCOCORTICOID;
MONOCLONAL ANTIBODY;
ADULT;
AGED;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DIABETIC MACULAR EDEMA;
DISEASE DURATION;
DRUG EFFICACY;
FEMALE;
GLAUCOMA;
HUMAN;
INTRAOCULAR PRESSURE;
LETTER;
MALE;
OPTICAL COHERENCE TOMOGRAPHY;
PIGMENT EPITHELIUM;
PRIORITY JOURNAL;
RETINA FOVEA;
RETINAL THICKNESS;
RETROSPECTIVE STUDY;
TREATMENT RESPONSE;
VISUAL ACUITY;
DIABETIC RETINOPATHY;
DRUG RESISTANCE;
INTRAVITREAL DRUG ADMINISTRATION;
MACULAR EDEMA;
MIDDLE AGED;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
TREATMENT OUTCOME;
ADULT;
AGED;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
DIABETIC RETINOPATHY;
DRUG RESISTANCE;
FEMALE;
GLUCOCORTICOIDS;
HUMANS;
INTRAVITREAL INJECTIONS;
MACULAR EDEMA;
MALE;
MIDDLE AGED;
TREATMENT OUTCOME;
TRIAMCINOLONE ACETONIDE;
VISUAL ACUITY;
|
|
EID: 84923229350
PISSN: 1755375X
EISSN: 17553768
Source Type: Journal
DOI: 10.1111/aos.12504 Document Type: Letter |
|
Times cited : (15)
|
|
References (5)
|
